Dental management considerations for a patient taking dabigatran etexilate: a case report

This publication has 15 references indexed in Scilit:

• National Trends in Oral Anticoagulant Use in the United States, 2007 to 2011
  Circulation: Cardiovascular Quality and Outcomes, 2012
• Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients
  Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2012
• Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
  Annals of Internal Medicine, 2011
• Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
  Thrombosis and Haemostasis, 2010
• Dabigatran versus Warfarin in Patients with Atrial Fibrillation
  New England Journal of Medicine, 2009
• Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran Etexilate
  Clinical Pharmacokinetics, 2008
• The Pharmacology and Management of the Vitamin K Antagonists
  Chest, 2004
• Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy
  American Heart Journal, 2004
• Lack of a scientific basis for routine discontinuation of oral anticoagulation therapy before dental treatment
  The Journal of the American Dental Association, 2003
• MYTHS OF DENTAL SURGERY IN PATIENTS
  The Journal of the American Dental Association, 2000